Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Regimens vs Tacrolimus + MMF in Kidney Transplant
NCT00275522Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplant rejection (3 arms), sponsored by Mayo Clinic. Primary endpoint: Calculated creatinine clearance at 12 months. Started Dec 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00275522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275522.